Advanced Medical Solutions (GB:AMS) has released an update.
Advanced Medical Solutions Group plc, a leader in developing innovative tissue-healing technologies, has announced its total voting rights with 217,673,628 ordinary shares as of July 31, 2024. This figure is crucial for shareholders to calculate their notification requirements for changes in company interest as per FCA rules. The company has a strong global presence, with a diverse portfolio of surgical and wound care products, and has expanded through several acquisitions since 2019.
For further insights into GB:AMS stock, check out TipRanks’ Stock Analysis page.
